Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_assertion type Assertion NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_head.
- NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_assertion description "[A substantial percentage of brain tumors overexpressed biomarkers associated with drug resistance, including MGMT (67%), GSTP1 (49%), and mutant p53 (41%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_provenance.
- NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_assertion evidence source_evidence_literature NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_provenance.
- NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_assertion SIO_000772 16899598 NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_provenance.
- NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_assertion wasDerivedFrom befree-2016 NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_provenance.
- NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_assertion wasGeneratedBy ECO_0000203 NP563593.RAu9FgPI6P0C0z6ZYTfBUNpm4FLnQQGQxYz9pDzqiwg5Y130_provenance.